Prevalence and risk factors of Hepatitis B and C in treatment naïve HIV positive patients

S. Reuter, M. Oette, F. C. Wilhelm, R. Kaiser, M. Balduin, F. Schweizer, J. Verheyen, O. Adams, B. Beggel, D. Häussinger & RESINA Studiengruppe
Introduction: In HIV treatment-naïve patients we analyzed the prevalence of serological and molecular markers for hepatitis B virus (HBV) and hepatitis C virus (HCV). We aimed at the identification of risk factors for chronic or occult hepatitis B infection (oHBV) and HCV infection. Patients,[for full text, please go to the a.m. URL]